Poly (ADP-Ribose) Polymerase Inhibitor, ABT888, Improved Cisplatin Effect in Human Oral Cell Carcinoma
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Poly (ADP-Ribose) Polymerase Inhibitor, ABT888, Improved Cisplatin Effect in Human Oral Cell Carcinoma
Authors
Keywords
-
Journal
Biomedicines
Volume 9, Issue 7, Pages 771
Publisher
MDPI AG
Online
2021-07-02
DOI
10.3390/biomedicines9070771
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PARP Inhibitors as Therapeutics: Beyond Modulation of PARylation
- (2020) Ahrum Min et al. Cancers
- Necroptosis in head and neck squamous cell carcinoma: characterization of clinicopathological relevance and in vitro cell model
- (2020) Jingyuan Li et al. Cell Death & Disease
- β-Caryophyllene Inhibits Cell Proliferation through a Direct Modulation of CB2 Receptors in Glioblastoma Cells
- (2020) Natasha Irrera et al. Cancers
- PARP Inhibitors as Therapeutic Options for Tyrosine Kinase-dependent Leukemia: A Review
- (2020) CAIO BEZERRA MACHADO et al. ANTICANCER RESEARCH
- Role of ABT888, a Novel Poly(ADP-Ribose) Polymerase (PARP) Inhibitor in Countering Autophagy and Apoptotic Processes Associated to Spinal Cord Injury
- (2020) Giovanna Casili et al. MOLECULAR NEUROBIOLOGY
- Combined PARP Inhibition and Immune Checkpoint Therapy in Solid Tumors
- (2020) Florent Peyraud et al. Cancers
- Efficacy of PARP Inhibition in Metastatic Castration-resistant Prostate Cancer is Very Different with Non-BRCA DNA Repair Alterations: Reconstructing Prespecified Endpoints for Cohort B from the Phase 3 PROfound Trial of Olaparib
- (2020) Konrad H. Stopsack EUROPEAN UROLOGY
- Prevalence and incidence of oral cancer in low‐ and middle‐income countries: A scoping review
- (2019) Aamod D. Shrestha et al. EUROPEAN JOURNAL OF CANCER CARE
- Survivin-Based Treatment Strategies for Squamous Cell Carcinoma
- (2018) Andrea Santarelli et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Analysis of PARP inhibitor toxicity by multidimensional fluorescence microscopy reveals mechanisms of sensitivity and resistance
- (2018) Jone Michelena et al. Nature Communications
- The comings and goings of PARP-1 in response to DNA damage
- (2018) John M. Pascal DNA REPAIR
- Cell-Active Small Molecule Inhibitors of the DNA-Damage Repair Enzyme Poly(ADP-ribose) Glycohydrolase (PARG): Discovery and Optimization of Orally Bioavailable Quinazolinedione Sulfonamides
- (2018) Bohdan Waszkowycz et al. JOURNAL OF MEDICINAL CHEMISTRY
- Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium
- (2018) Luca Falzone et al. Frontiers in Pharmacology
- Multiple mechanisms of dimethyl fumarate in amyloid β-induced neurotoxicity in human neuronal cells
- (2017) Michela Campolo et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Genetic etiology of oral cancer
- (2017) Johar Ali et al. ORAL ONCOLOGY
- Mechanisms of Invasion in Head and Neck Cancer
- (2015) Lizandra Jimenez et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- The Association of Palmitoylethanolamide with Luteolin Decreases Neuroinflammation and Stimulates Autophagy in Parkinson’s Disease Model
- (2015) Rosalba Siracusa et al. CNS & Neurological Disorders-Drug Targets
- SapC-DOPS nanovesicles induce Smac- and Bax-dependent apoptosis through mitochondrial activation in neuroblastomas
- (2015) Mahaboob K Sulaiman et al. Molecular Cancer
- Phase I study of olaparib in combination with liposomal doxorubicin in patients with advanced solid tumours
- (2014) G Del Conte et al. BRITISH JOURNAL OF CANCER
- Ovarian Cancer-associated Mutations Disable Catalytic Activity of CDK12, a Kinase That Promotes Homologous Recombination Repair and Resistance to Cisplatin and Poly(ADP-ribose) Polymerase Inhibitors
- (2014) Poorval M. Joshi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- New Insights into PARP Inhibitors' Effect on Cell Cycle and Homology-Directed DNA Damage Repair
- (2014) P. Jelinic et al. MOLECULAR CANCER THERAPEUTICS
- Regulated necrosis: the expanding network of non-apoptotic cell death pathways
- (2014) Tom Vanden Berghe et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Linifanib (ABT-869), enhances cytotoxicity with poly (ADP-ribose) polymerase inhibitor, veliparib (ABT-888), in head and neck carcinoma cells
- (2014) Heng-Wei Hsu et al. ORAL ONCOLOGY
- Proteomic Markers of DNA Repair and PI3K Pathway Activation Predict Response to the PARP Inhibitor BMN 673 in Small Cell Lung Cancer
- (2013) R. J. Cardnell et al. CLINICAL CANCER RESEARCH
- Review of Poly (ADP-ribose) Polymerase (PARP) Mechanisms of Action and Rationale for Targeting in Cancer and Other Diseases
- (2013) Julio Morales et al. CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION
- A Phase 1 trial of the poly(ADP-ribose) polymerase inhibitor olaparib (AZD2281) in combination with the anti-angiogenic cediranib (AZD2171) in recurrent epithelial ovarian or triple-negative breast cancer
- (2013) Joyce F. Liu et al. EUROPEAN JOURNAL OF CANCER
- The HSP90 inhibitor 17-N-allylamino-17-demethoxy geldanamycin (17-AAG) synergizes with cisplatin and induces apoptosis in cisplatin-resistant esophageal squamous cell carcinoma cell lines via the Akt/XIAP pathway
- (2013) TAKASHI UI et al. ONCOLOGY REPORTS
- Differential anti-proliferative activities of poly(ADP-ribose) polymerase (PARP) inhibitors in triple-negative breast cancer cells
- (2012) Hsiao-Ching Chuang et al. BREAST CANCER RESEARCH AND TREATMENT
- PARP-1 Inhibition as a Targeted Strategy to Treat Ewing's Sarcoma
- (2012) J. C. Brenner et al. CANCER RESEARCH
- Anti-Inflammatory Effects of Adrenomedullin on Acute Lung Injury Induced by Carrageenan in Mice
- (2012) Talero Elena et al. MEDIATORS OF INFLAMMATION
- The natural triterpene maslinic acid induces apoptosis in HT29 colon cancer cells by a JNK-p53-dependent mechanism
- (2011) Fernando J Reyes-Zurita et al. BMC CANCER
- PARP-1 cleavage fragments: signatures of cell-death proteases in neurodegeneration
- (2011) Ganta Chaitanya et al. Cell Communication and Signaling
- Progress in the Function and Regulation of ADP-Ribosylation
- (2011) M. O. Hottiger et al. Science Signaling
- Synergistic Chemosensitivity of Triple-Negative Breast Cancer Cell Lines to Poly(ADP-Ribose) Polymerase Inhibition, Gemcitabine, and Cisplatin
- (2010) K. Hastak et al. CANCER RESEARCH
- Mitotic homologous recombination maintains genomic stability and suppresses tumorigenesis
- (2010) Mary Ellen Moynahan et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Pifithrin-α protects against DNA damage-induced apoptosis downstream of mitochondria independent of p53
- (2009) D Sohn et al. CELL DEATH AND DIFFERENTIATION
- Inhibition of Poly(ADP-Ribose) Polymerase-1 Enhances Temozolomide and Topotecan Activity against Childhood Neuroblastoma
- (2009) R. A. Daniel et al. CLINICAL CANCER RESEARCH
- ABT-888 Confers Broad In vivo Activity in Combination with Temozolomide in Diverse Tumors
- (2009) J. P. Palma et al. CLINICAL CANCER RESEARCH
- Phyllanthus amarus Inhibits Cell Growth and Induces Apoptosis in Dalton's Lymphoma Ascites Cells Through Activation of Caspase-3 and Downregulation of Bcl-2
- (2009) Kuzhuvelil B. Harikumar et al. INTEGRATIVE CANCER THERAPIES
- Discovery of 2-{4-[(3S)-Piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide (MK-4827): A Novel Oral Poly(ADP-ribose)polymerase (PARP) Inhibitor Efficacious in BRCA-1 and -2 Mutant Tumors
- (2009) Philip Jones et al. JOURNAL OF MEDICINAL CHEMISTRY
- Phase I Study of the Poly(ADP-Ribose) Polymerase Inhibitor, AG014699, in Combination with Temozolomide in Patients with Advanced Solid Tumors
- (2008) R. Plummer et al. CLINICAL CANCER RESEARCH
- Recent Advances in Head and Neck Cancer
- (2008) Robert I. Haddad et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started